Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Baxter/Intramed

This article was originally published in The Gray Sheet

Executive Summary

Enter definitive merger agreement under which Intramed will become part of Baxter's Vascular Systems Division. Baxter will pay approximately $9.7 mil. ($2.72 per Intramed share) in Baxter stock for the San Diego manufacturer of flexible and rigid single- use endoscopes. The deal is expected to close by the end of May. As part of the agreement, two Intramed directors, Pieter Halter and Stephen Sosnowski, will resign from the board; replacements will be named by Baxter. For 1993, Intramed had sales of $3.1 mil. (down 5.6%) and a net loss of $2.1 mil

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002095

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel